Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vimal H Prajapati

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
JAAD International|June 20, 2022
Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart reviewRonald Vender, Irina Turchin, Perla Lansang, et al.
Journal of the American Academy of Dermatology|June 18, 2022
Management of morphea with systemic immunosuppressive therapies: An evidence-based reviewAbrahim Abduelmula, Brian D Rankin, Saba Riaz, et al.
Journal of the American Academy of Dermatology|December 6, 2017
A cross-sectional survey of long-term outcomes for patients with diffuse capillary malformation with overgrowthKevin X Liu, Vimal H Prajapati, Marilyn G Liang, et al.
Journal of Cutaneous Medicine and Surgery|November 7, 2019
Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section III: Treatment Options for Pediatric Atopic DermatitisPerla Lansang, Joseph M Lam, Danielle Marcoux, et al.
Journal of the American Academy of Dermatology|August 30, 2023
Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective studyJorge R Georgakopoulos, Dropen Sheka, Brian Rankin, et al.
Pediatric Dermatology|July 15, 2021
Predictors of family impact of juvenile localized sclerodermaKatia Milovanova, Merna Adly, Brendan C Lethebe, et al.
Dermatology and Therapy|June 25, 2024
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque PsoriasisLyn Guenther, Irina Turchin, Ron Vender, et al.
Journal of the American Academy of Dermatology|May 9, 2026
A practical framework for treating-to-target in chronic hand eczemaJensen Yeung, Melinda Gooderham, H Chih-Ho Hong, et al.
Journal of Cutaneous Medicine and Surgery|November 8, 2023
Use of Janus Kinase Inhibitor Treatment for Palmoplantar Pustulosis: An Evidence-Based ReviewSiddhartha Sood, Abrahim Abduelmula, Khalad Maliyar, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Merkel Cell Carcinoma of the Skin: Deducing the Pattern of Spread from an International Aggregated Database of 949 PatientsPatricia Tai, Kurian Joseph, Vimal H Prajapati, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
JAAD International|June 20, 2022
Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart reviewRonald Vender, Irina Turchin, Perla Lansang, et al.
Journal of the American Academy of Dermatology|June 18, 2022
Management of morphea with systemic immunosuppressive therapies: An evidence-based reviewAbrahim Abduelmula, Brian D Rankin, Saba Riaz, et al.
Journal of the American Academy of Dermatology|December 6, 2017
A cross-sectional survey of long-term outcomes for patients with diffuse capillary malformation with overgrowthKevin X Liu, Vimal H Prajapati, Marilyn G Liang, et al.
Journal of Cutaneous Medicine and Surgery|November 7, 2019
Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section III: Treatment Options for Pediatric Atopic DermatitisPerla Lansang, Joseph M Lam, Danielle Marcoux, et al.
Journal of the American Academy of Dermatology|August 30, 2023
Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective studyJorge R Georgakopoulos, Dropen Sheka, Brian Rankin, et al.
Pediatric Dermatology|July 15, 2021
Predictors of family impact of juvenile localized sclerodermaKatia Milovanova, Merna Adly, Brendan C Lethebe, et al.
Dermatology and Therapy|June 25, 2024
Canadian Expert Consensus on the Use of Halobetasol Propionate/Tazarotene Lotion for Plaque PsoriasisLyn Guenther, Irina Turchin, Ron Vender, et al.
Journal of the American Academy of Dermatology|May 9, 2026
A practical framework for treating-to-target in chronic hand eczemaJensen Yeung, Melinda Gooderham, H Chih-Ho Hong, et al.
Journal of Cutaneous Medicine and Surgery|November 8, 2023
Use of Janus Kinase Inhibitor Treatment for Palmoplantar Pustulosis: An Evidence-Based ReviewSiddhartha Sood, Abrahim Abduelmula, Khalad Maliyar, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Merkel Cell Carcinoma of the Skin: Deducing the Pattern of Spread from an International Aggregated Database of 949 PatientsPatricia Tai, Kurian Joseph, Vimal H Prajapati, et al.
Pageof 11